Skip to content

Exergaming for Better Physical Fitness

Effects of 8 Weeks of High-intensity Exergaming on Cardiorespiratory Fitness and Physical Activity Levels in Sedentary Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04112329
Enrollment
29
Registered
2019-10-02
Start date
2019-10-14
Completion date
2020-03-01
Last updated
2021-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sedentary Lifestyle

Keywords

Exercise therapy, Physical fitness, Gaming, Child, Healthy lifestyle, Fitness testing

Brief summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to increased physical activity, aerobic fitness and health benefits in sedentary adults. The project will include 28 sedentary adults, 18 years and above, who are not sufficiently active according to current guidelines defined as doing (\<150 minutes/week of moderate intensity physical activity or \<75 minutes/week of vigorous physical activity and/or do not do any regular endurance training ). The physical fitness (maximal oxygen consumption), blood pressure, body composition and objectively measured physical activity will be tested before and after the intervention period. Also, the participants gaming frequency will be registered throughout the 8 week period. Aim of this study is to investigate if access to this game can provide health benefits for adults who are not motivated to take part in regular physical activity.

Interventions

BEHAVIORALExergaming

will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks.

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Sedentary (\<150 mins of moderate intensity physical activity/week) and/or do not regularly take part in endurance training. * Able to ride a bike for up to 60 minutes

Exclusion criteria

* Known cardiovascular disease * Taking beta-blockers or anti-arrhythmic drugs

Design outcomes

Primary

MeasureTime frame
VO2max (Maximal Aerobic Capacity)8 weeks

Secondary

MeasureTime frameDescription
Daily average energy expenditure8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily average number of steps8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Daily average total physical activity duration8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).
Bioelectrical impedance8 weeksMeasured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (weeks).
Blood Pressure8 weeks

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026